AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Clinical trial NCT06346392 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06346392
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2026-05-31
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.